about
Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical propertiesRecent advancements in erythrocytes, platelets, and albumin as delivery systemsThe Prognostic Value of Platelet Count in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-AnalysisParaneoplastic thrombocytosis: the secrets of tumor self-promotionThrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysisRecent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingThrombocytosis and hepatocellular carcinoma.Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro.Platelet-related phenotypic patterns in hepatocellular carcinoma patients.Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection.The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis.Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines.Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6RGD-Binding Integrins in Head and Neck Cancers.Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer.Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In VitroPretreatment platelet count as a predictor for survival and distant metastasis in nasopharyngeal carcinoma patients.Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.In vivo optical imaging of cancer metastasis using multiphoton microscopy: a short review.Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.Modulation of Regorafenib effects on HCC cell lines by epidermal growth factorPlatelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinomaPretreatment platelet count improves the prognostic performance of the TNM staging system and aids in planning therapeutic regimens for nasopharyngeal carcinoma: a single-institutional study of 2,626 patients.Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent ApproachesClinical relevance of thrombocytosis in primary care: a prospective cohort study of cancer incidence using English electronic medical records and cancer registry data.Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort StudyThe independent association of platelet parameters with overall survival in pancreatic adenocarcinoma receiving intensity-modulated radiation therapyPrognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysisPretreatment thrombocytosis as a prognostic factor in metastatic breast cancerAssociation of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsyPlatelet function beyond hemostasis and thrombosisBiological role of prolyl 3-hydroxylation in type IV collagen.Cancer and Thrombosis: The Platelet Perspective.Pre-treatment platelet counts as a prognostic and predictive factor in stage II and III rectal adenocarcinoma.Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: A retrospective observational study.Doxorubicin-loaded platelets as a smart drug delivery system: An improved therapy for lymphomaThe impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis.RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.
P2860
Q21246016-6EAD31E7-81F3-4F7C-9AC7-82595A5E2CD9Q26747764-51E72DBB-623F-4A41-8CB3-C03047339F05Q26786170-2C7FB849-A900-4E3E-9AF6-D6B2A38D5FACQ26825427-DF4ADBB5-9819-4D03-B365-5B64AE5F805FQ26998730-88D10C82-6703-46B0-9945-22CBB998BC17Q30456053-0905099F-03B1-4D38-A175-3CA9A0D1DFDAQ33405280-10FB4B76-F922-42BD-8B28-FF869EF278A0Q33412956-1EC4DE03-38D3-41D2-B55C-DDADB1F523A7Q33416416-5ED6D79E-E551-44F5-92FF-7E1016AA5C2CQ33621633-AA0C9CB1-A74A-4026-9198-B14615C8D0D1Q33648477-8FCE5885-C4C8-4EEA-9418-75B7D4389D23Q33684043-5EC8EBBD-1564-46C8-A378-B1349F8E2245Q33822598-5249F340-A3E7-47CB-8FE7-80E7A2F28306Q33832735-40FF72FA-3EDE-45A0-A9CC-DA1A61753E39Q34577000-116AC7B5-7670-4257-8F79-250632E467B2Q34806144-4742E783-D365-4F7D-99C6-02971B49CAE6Q35042007-A223795A-AC25-4AF2-938C-0F4646245C5FQ35110810-A86335F8-1AC9-4C44-827F-E4E4C073CEEBQ35124116-F8C0EC90-9B8B-4A38-9186-2FDDBFC8BB48Q35189420-5A23D7A0-DF57-44B3-9FCE-818214350744Q35236584-5CF06BDB-5C12-4E02-851B-6529C7BE08B8Q35594262-E2F9BEC3-1743-49A5-A860-F82365E65F9CQ35639692-EEE90E79-A5B4-4359-8ADC-01FF6C7D39ECQ35692328-479C47F0-B3CA-426F-93EF-DC6A58C537AEQ36121373-6CBB1F26-537E-402D-A643-D70624691DE0Q36255936-1642898A-6697-40DB-84EC-4F1BFCCA525FQ36378241-FE60EDA6-25A6-4428-AC49-76ADFB353001Q36482461-DAF4ECCD-C002-4E6B-ADA7-0A7A0AC7D1DEQ36493047-81BB4531-5652-45A4-A830-33F694A18C86Q36650991-C0CAB93D-3E59-4A17-9494-7FF42A2A63C7Q36999374-2D39A8D0-DA34-4638-9069-0F4EC16FE7DDQ37415001-C1CA706F-4158-49B2-8F98-A4248D08D193Q37422974-830E0EFE-F6B0-4FCE-9014-23A61F888D91Q37475103-B1F9E523-2272-49DC-8ED7-52D838F51A3DQ37558436-AF58AF59-6565-4026-8EF6-28D249EDD339Q37590941-FE14E441-CD11-41C1-A3C9-B26610BA1A94Q37613385-6C4508F1-DF50-469B-9465-33A4450BE2EDQ37642601-389B5CC5-0F87-4ABC-BD9A-ABB567E13918Q38044830-2D257B90-74E0-4185-B03C-F1F63239C2FDQ38161395-5B805AE7-498D-4940-9706-2063E35D751F
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tumor-platelet interaction in solid tumors
@ast
Tumor-platelet interaction in solid tumors
@en
Tumor-platelet interaction in solid tumors
@nl
type
label
Tumor-platelet interaction in solid tumors
@ast
Tumor-platelet interaction in solid tumors
@en
Tumor-platelet interaction in solid tumors
@nl
prefLabel
Tumor-platelet interaction in solid tumors
@ast
Tumor-platelet interaction in solid tumors
@en
Tumor-platelet interaction in solid tumors
@nl
P2093
P2860
P3181
P356
P1476
Tumor-platelet interaction in solid tumors
@en
P2093
Christoph Groden
Daniel Buergy
Frederik Wenz
Marc A. Brockmann
P2860
P304
P3181
P356
10.1002/IJC.27441
P407
P577
2012-06-15T00:00:00Z